Immunoblotting was performed according to standard protocols using
following antibodies directed towards: EZH2 (CST, 3147),
H3K27me3 (Active Motif,
39155), H3 (CST, 9715),
H3K9ac (Active Motif, 61251),
β-actin (Sigma,
85316), MafB (Santa Cruz, sc-376387),
C/EBPβ C-terminal (Santa Cruz,
sc-150), C/EBPβ-LAP (CST, 3087), pPI3K-p85(Tyr458)/p55(Tyr199) (CST,
4228), pPDK1-Ser241 (CST, 3061), AKT (CST, 9272S), pAKT-Ser473 (CST, 4060), mTOR
(CST, 2983), pmTOR Ser2448 (CST, 2971), and pS6RP-Ser235/236 (CST, 2211)..
Nuclear and cytoplasmic protein separations were performed using the Nuclear
Extract Kit (Active Motif, 40010). Band signals were detected using Amersham ECL
Wstern Blotting Detection Reagent (GE Life Sciences, RPN2106) and analyzed and
quantitated using ProteinSimple Imager and AlphaView software (ProteinSimple,
CA).
Adamik J., Pulugulla S.H., Zhang P., Sun Q., Lontos K., Macar D.A., Auron P.E, & Galson D.L. (2019). EZH2 supports osteoclast differentiation and bone resorption via epigenetic and cytoplasmic targets. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 35(1), 181-195.